Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,661
Closed -$512K 2154
2026
Q1
$512K Sell
3,661
-4,054
-53% -$739K ﹤0.01% 1542
2025
Q4
$1.38M Buy
+7,715
New +$1.32M ﹤0.01% 1211
2025
Q3
Sell
-7,946
Closed -$1.64M 1668
2025
Q2
$1.64M Sell
7,946
-1,745
-18% -$324K ﹤0.01% 1121
2025
Q1
$1.45M Sell
9,691
-5,229
-35% -$1.81M ﹤0.01% 1235
2024
Q4
$6.09M Buy
14,920
+14,837
+17,876% +$5.28M ﹤0.01% 953
2024
Q3
$26.7K Buy
+83
New +$22.9K ﹤0.01% 1893
2024
Q2
Sell
-3,877
Closed -$951K 2031
2024
Q1
$951K Sell
3,877
-6,474
-63% -$1.76M ﹤0.01% 1294
2023
Q4
$2.81M Buy
+10,351
New +$2.67M ﹤0.01% 1107
2022
Q4
Sell
-12
Closed -$3K 1966
2022
Q3
$3K Buy
+12
New +$3.24K ﹤0.01% 1818

Other funds holding RH

Amundi's RH Position: Q2 2026 in Review

Amundi sold out of RH (RH) in Q2 2026, closing a stake of 3,661 shares — an estimated $512K sold.

Amundi first reported a position in RH in Q3 2022 and held it in 9 quarters. The position peaked at $6.09M in Q4 2024. 373 funds tracked by Wall St. Rank hold RH as of Q2 2026.

  • Amundi reported no remaining RH position as of Q2 2026 after selling out during the quarter.
  • Amundi sold 3,661 RH shares in Q2 2026, an estimated $512K.
  • Amundi first reported a position in RH in Q3 2022 and held it in 9 quarters.
  • Amundi's RH position peaked at $6.09M in Q4 2024.
  • 373 funds tracked by Wall St. Rank held RH as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.